Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...
A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes, or another condition. And we expect that number to rise now that ...
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal ...
If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering ...
The blitz reflects a broader shift toward direct-to-consumer marketing with the launch of new pill versions of the GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results